Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007801
Filing Date
2019-08-09
Accepted
2019-08-09 07:06:19
Documents
82
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q neos-20190630x10q.htm 10-Q 2901586
2 EX-31.1 neos-20190630ex3114432b8.htm EX-31.1 15072
3 EX-31.2 neos-20190630ex312a435d5.htm EX-31.2 15562
4 EX-32.1 neos-20190630ex32153ca97.htm EX-32.1 10268
  Complete submission text file 0001558370-19-007801.txt   10383321

Data Files

Seq Description Document Type Size
5 EX-101.INS neos-20190630.xml EX-101.INS 2112987
6 EX-101.SCH neos-20190630.xsd EX-101.SCH 72343
7 EX-101.CAL neos-20190630_cal.xml EX-101.CAL 77358
8 EX-101.DEF neos-20190630_def.xml EX-101.DEF 303933
9 EX-101.LAB neos-20190630_lab.xml EX-101.LAB 682133
10 EX-101.PRE neos-20190630_pre.xml EX-101.PRE 545292
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

EIN.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37508 | Film No.: 191011286
SIC: 2834 Pharmaceutical Preparations